Search results

PI Lars Rönnstrand BackgroundThe receptor tyrosine kinases KIT and FLT3 are both important regulators of development and maintenance of a number of different cell types. Deregulation of these receptors by mutations has been implicated in various human malignancies, including akut myeloid leukemia and melanoma. The signaling pathways activated by the oncogenic mutants are to some extent unique and

https://www.tcr.lu.se/research-groups/molecular-cancer-research - 2026-05-21

PI Kazi Julhash Uddin BackgroundDespite incredible progress in the treatment of cancer, the cure rate remains low due to the fact that almost all cancer patients develop resistance to anticancer therapies.  This results in as many as 90% of cancer-related deaths in various types of cancer. Consequently, identification of the factors that drive the development of therapy resistance is a pressing is

https://www.tcr.lu.se/research-groups/molecular-cancer-medicine - 2026-05-21

Joakim Esbjörnsson, PhDAssociate Professor in VirologySenior Lecturer in Medical MicrobiologyHead of Systems Virology GroupDepartment of Translational MedicineFaculty of MedicineLund UniversityPostal address:Lund UniversityBMC, B13221 84 LundSwedenPhone: +46 46 22 20119, Officeemail: joakim [dot] esbjornsson [at] med [dot] lu [dot] se   Honorary Visisting Research Fellow Nuffield Department of Med

https://www.virology.lu.se/contact - 2026-05-21

Acute HIV-1 infectionViral evolution and innate immune responses during acute adult HIV-1 infection and their association with disease pathogenesisIt has been suggested that different virological and immunological events during the very early stages of HIV infection may determine the rate of the future disease course of the individual patient. Previous studies by us and others have suggested that

https://www.virology.lu.se/virology.lu.se/systems-virology - 2026-05-21

a Areas asp

https://www.virology.lu.se/projects - 2026-05-21

a

https://www.virology.lu.se/research - 2026-05-21

a

https://www.virology.lu.se/clinical-virology-team - 2026-05-21

a

https://www.virology.lu.se/clinical-virology-team-0 - 2026-05-21

Long-standing collaboration and fieldwork in Guinea-Bissau, West Africa, has made Lund University one of the leading institutions in the world when it comes to HIV-2 research. The virology research in Lund has access to multiple high-end experimental platforms encapsulating molecular as well as cell biology techniques to support cutting-edge HIV research. This also includes modern BSL-3 facilities

https://www.virology.lu.se/systems-virology - 2026-05-21

a Areas

https://www.virology.lu.se/clinical-virology/projects - 2026-05-21

Patrik Medstrand Professor Read about Patrik in the Research Portal Patrik´s publications                               Sara Karlson    Senior Laboratory Assistant   MSc. Biomedicine   Read about Sara in the Research Portal   Sara's publications " HIV research has always been very intriguing to me and this contributes to my long-term interest in the field. Working as a lab technician for three dif

https://www.virology.lu.se/clinical-virology/clinical-virology-team - 2026-05-21

  Marianne JanssonPhD, Professor Read about Marianne in the Research PortalMarianne´s publications "My research is focused on understanding HIV host interactions and the impact these have on disease progression, by deciphering mechanisms behind protective and pathogenic immune responses in HIV-1 and HIV-2 infections. The goal is to contribute to optimized treatment and provide clues to how an effe

https://www.virology.lu.se/hiv-host-interactions/hiv-host-interactions-team - 2026-05-21

Stefan Schwartz, PIRead about Stefan in the Research PortalNaoko Kajitani, researcherRead about Naoko in the Research PortalXiaoxu Cui, graduate studentRead about Xiaoxu in the Research PortalChengyu Hao, graduate studentRead about Chengyu in the Research PortalJohanna Jönsson, graduate studentRead about Johanna in the Research PortalYunji Zheng, graduate studentRead about Yunji in the Research Po

https://www.virology.lu.se/molecular-virology/molecular-virology-team - 2026-05-21

Project I Studies on the impact of HIV-2 low level viremia on immunopathogenesis Project II Studies on immune responses and viral reservoirs in HIV-2 extreme elite controllers  Project III Studies on type 1 interferon signaling in HIV-1 and HIV-2 infections  Project IV Studies on the incorporation and structure of HIV-2 envelope glycoproteins  Areas Project I Studies on the impact of HIV-2 low lev

https://www.virology.lu.se/hiv-host-interactions/projects - 2026-05-21

Molecular virology - - Lund University   Areas

https://www.virology.lu.se/molecular-virology/projects - 2026-05-21

a Principal Investigator

https://www.virology.lu.se/clinical-virology/patrik-medstrand - 2026-05-21

PATRIK MEDSTRAND Patrik Medstrand_LUCRIS Patrik Medstrand_PubMed

https://www.virology.lu.se/clinical-virology/publications - 2026-05-21

a

https://www.virology.lu.se/clinical-virology/collaborators - 2026-05-21

Patrik Medstrand, Professor E-post: patrik [dot] medstrand [at] med [dot] lu [dot] se (patrik[dot]medstrand[at]med[dot]lu[dot]se) Professor vid Klinisk virologi, Malmö Telefon: +46 46 222 14 89 Mobil: +46 70 841 57 97 Rumsnummer: BMC B1354b Professor vid EpiHealth: Epidemiology for Health Chef vid Klinisk virologi, Malmö Forskargruppschef vid Klinisk virologi, Malmö

https://www.virology.lu.se/clinical-virology/contact - 2026-05-21

HIV-1 and HIV-2 host interactions - - Lund University Karlsson I, Tingstedt JL, Sahin GÖ, Hansen M, Szojka Z, Buggert M, Biague A, Da Silva Z, Månsson F, Esbjörnsson J, Norrgren H, Medstrand P, Fomsgaard A*, and Jansson M*; Sweden-Guinea-Bissau Cohort Research Group. Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted ADCC Identified in HIV-2-Infected Indivi

https://www.virology.lu.se/hiv-host-interactions/marianne-jansson - 2026-05-21